Skip to content
  • Our Work
    • Fields
      • Cardiology
      • ENT
      • Gastro
      • Orthopedics
      • Ophthalmology
      • Pulmonology
      • Surgical Intelligence
      • Surgical Robotics
      • Urology
      • Other
    • Modalities
      • Endoscopy
      • Medical Segmentation
      • Microscopy
      • Ultrasound
  • Success Stories
  • Insights
    • Magazine
    • Upcoming Events
    • Webinars
    • Meetups
    • News
    • Blog
  • The company
    • About us
    • Careers
Menu
  • Our Work
    • Fields
      • Cardiology
      • ENT
      • Gastro
      • Orthopedics
      • Ophthalmology
      • Pulmonology
      • Surgical Intelligence
      • Surgical Robotics
      • Urology
      • Other
    • Modalities
      • Endoscopy
      • Medical Segmentation
      • Microscopy
      • Ultrasound
  • Success Stories
  • Insights
    • Magazine
    • Upcoming Events
    • Webinars
    • Meetups
    • News
    • Blog
  • The company
    • About us
    • Careers
Contact

AI in Cardiac CT angiography

Coronary computed tomography angiography (CCTA) is an efficient and non-invasive imaging modality with widespread clinical implementation in the identification of coronary artery disease (CAD). With rapid 3D visualization of coronary arteries and heart, including visualization of blood flow in arteries and capillaries, CCTA enables accurate monitoring of the coronary tree for blockages and other pathologies, yet, some major challenges remain to be met to maximize its clinical value.

Complexity of CCTA Analysis:

diagnostic accuracy of CCTA.

The diagnostic value of CCTA relies on manual assessment of a 3D model of the coronary tree consisting of numerous image slices. However, the complexity of these images makes this task time-consuming and difficult. Image artifacts, from motion, arrhythmia, calcified plaque, patient size, and other factors, further complicate the
Deep learning is automating segmentation and facilitating the identification of blockages and other anomalies while increasing accuracy and time savings.
Methods – One DL method is segmenting the LV in CCTA using a multiscale patch-based CNN. This is a two-stage method. In the first stage, three CNNs are dispatched to detect a bounding box around the LV. In the second stage, CNNs are used to perform voxel classification.
Another method involves using a LSTM RNN to automatically label segments in the coronary artery tree, trained using hundreds of CCTA images. The RNN, is proven to successfully learn the topology and spatial location of blood vessels and capture the coronary tree structure characteristics while presenting robust results.
Results – DL based approaches, such as CNN and RNN, successfully segment the coronary tree structure and characteristics, reducing complexity and time burden of CCTA interpretation and achieving a higher accuracy rate than classical approaches. A future challenge is to handle even the most complicated pathologies while maintaining a high accuracy rate.

Stenosis Detection:

CTTA has a high negative predictive value, making this modality a suitable tool for excluding significant coronary artery calcification (CAC). However, despite this high sensitivity, CTTA has limited specificity for identifying atherosclerotic plaque and functionally significant stenosis. Non-conclusive analysis leads to increased rates of invasive procedures, such as fractional flow reserve (FFR) measurement during ICA, and delayed CAD management.
Methods – A two-stage DL method may be used to identify CCTA image voxels that represent coronary artery calcification. The method uses two separate CNNs. The first segments the image and identifies potential calcification, and the second CNN classifies only the voxels selected by the first CNN to identify functional significance. This approach achieves a high rate of accuracy.
Another method uses a Support Vector Machine (SVP) trained to evaluate CCTA images for stenosis, thereby facilitating the identification of patients with functionally significant stenosis.
Results – DL architectures are more sensitive and quicker in identifying functionally significant stenosis than standard CCTA which despite high negative predictive value in exclusion is less efficient at detecting and identifying CAC and functionally significant stenosis.

Low-Dose Contrast Analysis:

The usage of contrast agents in CCTA improves image quality and segmentation accuracy contributing to overall diagnostic efficiency. However, patient safety is compromised by increased dosage.
On the other hand, dose reduction increases noise and artifact interference, impacting image interpretation and making classic CV tolls less effective. DL algorithms are enhancing low dose CCTA image quality, thereby lowering dose radiation for contrast CCTA and improving clinical analysis.
Methods – Different approaches are addressing the above challenges. One uses an FCNN trained on 3D CCTA data patches to predict routine dose images from low dose CCTA data patches. Simulated and real low dose scans were associated with a 90% dose reduction. An additional 2D CNN was utilized for improving denoising.
Other methods use a GAN to denoise low-dose CCTA images and reconstruct low-dose images into routine-dose CCTA images, or use an SSDA-based CNN to reconstruct, denoise, and inpaint low-dose CCTA images.
Results – Several CNNs are effective at predicting and reconstructing low dose CCTA images to emulate the image quality of routine dose CCTA images. These results have been validated, showing that using fast and high-quality DL algorithmic denoising may contribute to radiation dose reduction of 90%, thereby improving patient safety while enhancing image quality.

RSIP at the Heart of Cardiac Imaging

RSIP Vision is a first-mover in deep learning for CT, at the heart of AI for cardiac care. Click here for more information about our computer vision solutions for cardiology.

Share

Share on linkedin
Share on twitter
Share on facebook

Main Field

Cardiology

RSIP Vision’s advanced algorithms and image processing software (together with proper machines and devices) are used by physicians and researchers to develop and perform preventive and interventional cardiovascular procedures: that's our contribution to Artificial Intelligence in cardiology. Our software provides information about the patient’s cardiovascular system in a non-invasive manner, helps physicians ensure accuracy during complex operations, raises the level of patient safety through limiting his/her exposure to radiation, and aids diagnosis. We come to the office to write algorithms that save lives. In this section about computer vision in cardiology you can discover some of the ways we do it.

View Cardiology

Categories

  • Cardiology, RSIP Vision Learns

Related Content

PR – Non-Invasive Planning of Coronary Intervention

Coronary Arteries Segmentation

Great Vessels Segmentation with Deep Learning

Cardiac Motion Correction

Deep Learning in Cardiology

Cardiac MRI 3D automatic segmentation

3D Cardiac MRI automatic segmentation

3D Reconstruction of the heart

3D reconstruction of the heart

PR – Non-Invasive Planning of Coronary Intervention

Coronary Arteries Segmentation

Great Vessels Segmentation with Deep Learning

Cardiac Motion Correction

Deep Learning in Cardiology

Cardiac MRI 3D automatic segmentation

3D Cardiac MRI automatic segmentation

3D Reconstruction of the heart

3D reconstruction of the heart

Show all

RSIP Vision

Field-tested software solutions and custom R&D, to power your next medical products with innovative AI and image analysis capabilities.

Read more about us

Get in touch

Please fill the following form and our experts will be happy to reply to you soon

Recent News

PR – Intra-op Virtual Measurements in Laparoscopic and Robotic-Assisted Surgeries

PR – Non-Invasive Planning of Coronary Intervention

PR – Bladder Panorama Generator and Sparse Reconstruction Tool

PR – Registration Module for Orthopedic Surgery

All news
Upcoming Events
Stay informed for our next events
Subscribe to Our Magazines

Subscribe now and receive the Computer Vision News Magazine every month to your mailbox

 
Subscribe for free
Follow us
Linkedin Twitter Facebook Youtube

contact@rsipvision.com

Terms of Use

Privacy Policy

© All rights reserved to RSIP Vision 2021

Created by Shmulik

  • Our Work
    • title-1
      • Ophthalmology
      • Uncategorized
      • Ophthalmology
      • Pulmonology
      • Cardiology
      • Orthopedics
    • Title-2
      • Orthopedics
  • Success Stories
  • Insights
  • The company